Navigation Links
Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries

Diflucan Partnership seems to be the latest mantra of Pfizer. The pharmaceutical giant has announced that it will supply free antifungal drug to 50 countries hardest hit by the AIDS virus. The decision by the Pfizer comes close on the heels of the South African Government winning a landmark case against pharmaceutical companies. In an announcement on Wednesday Pfizer said AIDS related antifungal drug Diflucan will be given free of cost to battle HIV through a programe to be coordinated by World Health Organization and the United Nations.

"Together with our partners in the United Nations and the WHO, we now have a framework to offer Diflucan to the least-developed nations targeted by the UN and the WHO as the most affected by the AIDS crisis", Dr.Henry McKinnell, CEO of Pfizer, told reporters at a press conference.

Many patients stricken with AIDS develop complication of fungal origin. Two common conditions are esophageal candidiasis and cryptococcal meningitis. Flucanazole, commerically available as Diflucan is used to treat these conditions.

Representatives of Pfizer Inc. said they do not know how much the expanded 50-nation program would cost. However, they said that expenses of the project, called the Diflucan Partnership, would include drug manufacturing, shipping, transportation, medical training and patient education.
'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Medicis Pharmaceutical company enters pediatric market
3. Pharmaceutical companies are targeting patients
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
7. Pharmaceutical industries grant for R&D to be monitored
8. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Top Pharmaceuticals Influence Doctors Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... ... April 28, 2016 , ... In many parts of the world, ... childhood mortality. This is particularly true in underdeveloped parts of Africa where clean sources ... New England’s campus in Tangier, Morocco, will examine this global health issue and consider ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Infrastructure Management solutions, announces today the availability of its latest software release, ... of capacity management and optimization, providing new analytical capabilities that assess complex ...
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of non-medical in-home ... – its San Antonio West location. Prior to entering the senior care industry, Amada ... opening of Amada San Antonio West will take place on Friday, April 29th. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Collaboration Platform™ , today announced a new Residency Education & Collaboration Platform ... medical knowledge, educational resources, and a host of collaboration tools designed to ...
(Date:4/28/2016)... PA (PRWEB) , ... April 28, 2016 , ... ... Browne, M.D. has been named a Top Doc in Physical Medicine and Rehabilitation ... conjunction with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Research and ... Plastic Surgery Products Market 2016-2020" report to their ... , The global plastic surgery products market ... during the period 2016-2020. , ,The growing adoption of ... the growth of the market. Lasers are used to ...
(Date:4/28/2016)... April 28, 2016 , Net Sales of ... basis over the prior year period, and an increase of ... , Diluted EPS for the first quarter were $0.52 reported, ... $2.00 adjusted, an increase of 29.9% over the prior year ... adjusted earnings guidance for 2016 Zimmer Biomet Holdings, ...
(Date:4/28/2016)... 2016 TapImmune,Inc. (TPIV), a ... and gene-based immunotherapeutics and vaccines for the treatment of cancer ... the 3rd Annual Growth Capital Expo to be ... at Caesars Palace in Las Vegas, Nevada.  The Company ... 4 th by Dr. John N. Bonfiglio ...
Breaking Medicine Technology: